Concepedia

Katya Rubinstein

KR

Statistics

Publications

8

Citations

140

H-Index

8

Active since

1954

Affiliations

Sheba Medical Center(Current)

Tel Aviv University

Parc Sanitari Sant Joan de Déu

Centro de Investigación Biomédica en Red de Salud Mental

Hospital de Sant Pau

Katya Rubinstein is an author at Sheba Medical Center specializing in medicine, psychiatry, and schizophrenia spectrum disorders.

ORCID

Publications per year

1954–2023

8

Publications

8

A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder

Mark Weiser, Ari A. Gershon, Katya Rubinstein et al. · Schizophrenia Research · 2012 · 33 citations

, , +12

Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study.

Revital Amiaz, Ilan Kent, Katya Rubinstein et al. · PubMed · 2015 · 25 citations

, , +16

Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study

Elena Huerta‐Ramos, María Soledad Escobar, Katya Rubinstein et al. · JMIR mhealth and uhealth · 2016 · 24 citations · Full text

, , +15

Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers

Anna Alonso-Solís, Katya Rubinstein, Iluminada Corripio et al. · BMJ Open · 2018 · 15 citations · Full text

, , +11

A Diet and Fitness Program Similarly Affects Weight Reduction in Schizophrenia Patients Treated with Typical or Atypical Medications

Revital Amiaz, Katya Rubinstein, Efrat Czerniak et al. · Pharmacopsychiatry · 2016 · 13 citations

, , +16

1–5 of 8